Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study.

Patrick M Moriarty,Eli M Roth,Adam Karns,Ping Ye,Shui-Ping Zhao,Yuhua Liao,David M Capuzzi,Harold E Bays,Fumin Zhang,Shaowen Liu,Alan J Reichman,Osvaldo A Brusco,Guoping Lu,Sam Lerman,Zhenwen Duan,Shuren Guo,Ping Lan Liu,Junxian Zhao,Yan Zhang,Simon Li

DOI: https://doi.org/10.1016/j.jacl.2014.09.002

IF: 5.365

2014-01-01

Journal of Clinical Lipidology

Abstract:►Xuezhikang (XZK) is an extract of red yeast rice with lipid-lowering effects.►Daily XZK 1200 to 2400 mg for 12 weeks decreased non−HDL-C by approximately 24% and LDL-C by approximately 27%.►XZK treatment at either dose enabled approximately 50% of patients to achieve a ≥30% decrease in LDL-C.►Xuezhikang was well tolerated. No subject developed myopathy.►Efficacy did not differ in American vs Chinese subjects.